Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast—implications for tumor biology and pathological diagnosis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gcc.22256PMID 25931199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phyllodes tumor of the breast

  2015cited by this paper
• MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma

  2014influential reference
• Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms.

  2014influential reference
• COSMIC: exploring the world's knowledge of somatic mutations in human cancer

  2014cited by this paper
• Mutations in POLE and survival of colorectal cancer patients – link to disease stage and treatment

  2014cited by this paper
• Mediator subunit 12 coordinates intrinsic and extrinsic control of epithalamic development.

  2014cited by this paper
• The Arabidopsis Mediator CDK8 module genes CCT (MED12) and GCT (MED13) are global regulators of developmental phase transitions

  2014cited by this paper
• MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.

  2014cited by this paper
• Malignant Phyllodes Tumor of the Breast: Treatment and Prognosis

  2014cited by this paper
• Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma

  2014influential reference
• Myoepithelial and epithelial–myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012

  2013cited by this paper
• MED12 exon 2 mutations in histopathological uterine leiomyoma variants

  2013cited by this paper
• MED12 mutations in leiomyosarcoma and extrauterine leiomyoma

  2013cited by this paper
• Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours

  2013cited by this paper
• MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors

  2013cited by this paper
• Breast phyllodes tumor: a review of literature and a single center retrospective series analysis.

  2013cited by this paper
• Recent insights into the molecular pathogenesis of mammary phyllodes tumours

  2013cited by this paper
• MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.

  2012cited by this paper
• WHO classification of tumours of the breast

  2012cited by this paper
• Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors

  2012influential reference
• Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas

  2012cited by this paper
• Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

  2012cited by this paper
• MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

  2011cited by this paper
• Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling

  2010cited by this paper
• The human Mediator complex: a versatile, genome-wide regulator of transcription.

  2010cited by this paper
• PIK3CA hotspot mutation scanning by a novel and highly sensitive high-resolution small amplicon melting analysis method.

  2010cited by this paper
• Recurrent challenges in the evaluation of fibroepithelial lesions.

  2009cited by this paper
• A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra‐tumoral genetic heterogeneity and new genetic changes on recurrence

  2008cited by this paper
• Phyllodes tumor of the breast.

  2008cited by this paper
• Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast

  2007cited by this paper
• Mediator Is a Transducer of Wnt/β-Catenin Signaling*

  2006cited by this paper
• Mediator is a transducer of Wnt/beta-catenin signaling.

  2006influential reference
• Mediator Modulates Gli3-Dependent Sonic Hedgehog Signaling

  2006influential reference
• Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations.

  2001cited by this paper
• Phyllodes Tumors of the Breast: A Review of 32 Cases

  2000cited by this paper
• The treatment and prognosis of patients with phyllodes tumor of the breast: An analysis of 170 cases

  1996cited by this paper
• p53 mutations in benign breast tissue.

  1995cited by this paper
• Long-term risk of breast cancer in women with fibroadenoma.

  1994influential reference

• A Rare Case of Malignant Phyllodes Tumor of the Breast in a Patient With a History of Recurrent Fibroadenomas: A Case Report and Literature Review

  2025cites this paper
• Genetic and immunohistochemical studies identify recurrent ACTB mutations and PTEN alterations in tubular adenomas of the breast.

  2025cites this paper
• Fibroepithelial Lesions: An Update for Daily Practice (Part-I).

  2025cites this paper
• Integrated multi-omics profiling reveals a clinically relevant molecular feature and potential therapeutic target on phyllodes tumors of breast

  2024cites this paper
• Periductal Stromal Tumor of the Breast with a TERT Promoter Mutation: First Case Report with Comprehensive Molecular Analysis

  2023cites this paper
• Variants in exon 2 of MED12 gene causes uterine leiomyoma's through over-expression of MMP-9 of ECM pathway.

  2023cites this paper
• FIBROADENOMA MAMÁRIO: O QUE HÁ DE NOVO NA LITERATURA?

  2023cites this paper
• Changes in the mammary gland during aging and its links with breast diseases

  2023cites this paper
• Secondary epidural and para-vertebral localization of a phyllodes sarcoma of the breast, case report

  2022cites this paper
• Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.

  2022cites this paper
• Classic illustrations of benign and malignant phyllodes breast tumors in two patients

  2022cites this paper
• Fibroepithelial Lesions of the Breast.

  2022cites this paper
• Phyllodes Tumors

  2021cites this paper
• Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata

  2021cites this paper
• Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing

  2021cites this paper
• Malignant Phyllodes Tumor With Metastases to the Femur the Lung and Bilateral Axillas: A Case Report and Review of Literature

  2021cites this paper
• Fibroepithelial lesions revisited: implications for diagnosis and management

  2020cites this paper
• Genotype‐phenotype associations in breast pathology: Achievements of the past quarter century

  2020cites this paper
• Morphologic and genetic heterogeneity in breast fibroepithelial lesions—a comprehensive mapping study

  2020cites this paper
• Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations

  2020cites this paper
• Histopathologic, immunophenotypic, and proteomics characteristics of low-grade phyllodes tumor and fibroadenoma: more similarities than differences

  2020cites this paper
• Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations

  2020cites this paper
• Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors

  2020cites this paper
• Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.

  2020cites this paper
• Histopathologic, immunophenotypic, and proteomics characteristics of low-grade phyllodes tumor and fibroadenoma: more similarities than differences

  2020cites this paper
• Genomic characterisation of breast fibroepithelial lesions in an international cohort

  2019cites this paper
• Cytological criteria of differentiation of phyllodes tumor of the breast and fibroadenoma

  2019cites this paper
• Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids

  2019cites this paper
• Myome – was liegt da in der DNA?

  2019cites this paper
• Molecular insights into paediatric breast fibroepithelial tumours

  2018cites this paper
• MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours

  2018cites this paper
• Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL

  2018cites this paper
• MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women

  2018cites this paper
• Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults

  2018cites this paper
• Factors targeting MED12 to drive tumorigenesis?

  2018cites this paper
• Μελέτη σηματοδοτικών οδών που εμπλέκονται στην επιθηλιο-μεσεγχυματική μετατροπή στους φυλλοειδείς όγκους μαστού

  2018cites this paper
• Pathology and Molecular Pathology of Breast Cancer

  2017cites this paper
• Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast

  2017cites this paper
• Med12 regulates ovarian steroidogenesis, uterine development and maternal effects in the mammalian egg †

  2017cites this paper
• Fibroepithelial lesions; The WHO spectrum.

  2017cites this paper
• Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy

  2017cites this paper
• Genetics and genomics of breast fibroadenomas

  2017cites this paper
• Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis‐generating study

  2017cites this paper
• Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K–AKT pathway

  2017cites this paper
• Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.

  2016cites this paper
• Mutations in genes encoding PI3K‐AKT and MAPK signaling define anogenital papillary hidradenoma

  2016cites this paper
• MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression

  2016cites this paper
• MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast

  2016cites this paper
• Phyllodes Tumor in a Lactating Breast

  2016cites this paper
• The Role of Mediator Complex Subunit 12 in Leiomyoma Biology

  2016cites this paper
• Molecular classification of uterine leiomyomas by genome-wide methods

  2016cites this paper
• THE ROLE OF MED 12 IN TUMORIGENESIS

  2016cites this paper
• Mesenchymal tumours of the breast and their mimics: a review with approach to diagnosis.

  2016cites this paper
• The stem cell renewal and DNA damage response pathways are frequently altered in fibroepithelial tumors of breast in Indian patients.

  2016cites this paper
• Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

  2016influential citation
• Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology

  2016cites this paper
• Phyllodes tumours of the breast: a consensus review

  2016cites this paper
• Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity

  2016cites this paper
• Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.

  2016cites this paper
• The role of mediator complex subunit 12 (MED12) in the murine reproductive tract

  2015cites this paper
• Genetic alterations in uterine fibroids – a new direction for pharmacological intervention?

  2015cites this paper
• Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing

  2015cites this paper
• MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases

  2015cites this paper
• Insulin-like growth factor Ⅱmessenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast

  year unknowncites this paper